Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01326676Phase 3Withdrawn
A Phase 3 trial of Red Heart Pill in cardiovascular disease (CVD), sponsored by Imperial College London. Planned start Feb 2011; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01326676.